PDD Behavior Inventories: Clinical and Research Applications to ASD

Reference work entry


This chapter describes the PDD Behavior Inventory (PDDBI) and PDD Behavior Inventory-Screening Version (PDDBI-SV) which are relatively new informant-based rating scales useful clinically and for research studies. The information gathered from the PDDBI is unique in that it provides dimensional assessment of both problem behaviors and adaptive skills. Further, the scores that are derived are standardized on children with autism spectrum disorder (ASD) and take age into account. This enables the clinician or researcher to ascertain, for an individual case, whether scores are typical or atypically low or high for a child with ASD thereby facilitating identification of possible comorbid problems. The clinical applicability of the PDDBI and the importance of the behavior profiles revealed by this assessment instrument are described first using four case vignettes. This is followed by description of the role of the PDDBI in research using, as an example, a study which identified clinical subtypes of boys with ASD based on their and their mother’s monoamine oxidase A (MAOA) genotype. Finally, the new PDDBI-SV, a rapid screening tool for ASD which was published in 2011, is described along with issues involved in screening rare disorders. It was concluded that the PDDBI and PDDBI-SV are assessment tools that provide important information not usually found with other measures.


Depression Serotonin Triad Monoamine Cote 


  1. Adams JB, Audhya T, McDonough-Means S, et al. Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr Metab (Lond). 2011;8(1):34.CrossRefGoogle Scholar
  2. Allen DA. Autistic spectrum disorders: clinical presentation in preschool children. J Child Neurol. 1988;3(Suppl):S48–56.PubMedCrossRefGoogle Scholar
  3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Fourth edition text revision. Washington, DC; 2000.Google Scholar
  4. Autism and Developmental Disabilities Monitoring Network, United States. Prevalence of autism spectrum disorders, 2006. MMWR Surveill Summ. 2009;58(10):1–20.Google Scholar
  5. Bent S, Bertoglio K, Ashwood P, Nemeth E, Hendren RL. Brief report: hyperbaric oxygen therapy (HBOT) in children with autism spectrum disorder: a clinical trial. J Autism Dev Disord. 2012;42(6):1127–32.PubMedCrossRefGoogle Scholar
  6. Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science. 1993;262(5133):578–80.PubMedCrossRefGoogle Scholar
  7. Buckholtz JW, Meyer-Lindenberg A. MAOA and the neurogenetic architecture of human aggression. Trends Neurosci. 2008;31(3):120–9.PubMedCrossRefGoogle Scholar
  8. Caspi A, McClay J, Moffitt TE, et al. Role of genotype in the cycle of violence in maltreated children. Science. 2002;297(5582):851–4.PubMedCrossRefGoogle Scholar
  9. Cerasa A, Gioia MC, Fera F, et al. Ventro-lateral prefrontal activity during working memory is modulated by MAO A genetic variation. Brain Res. 2008;1201:114–21.PubMedCrossRefGoogle Scholar
  10. Chauhan A, Chauhan V, Brown WT, Cohen IL. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin – the antioxidant proteins. Life Sci. 2004;75:2539–49.PubMedCrossRefGoogle Scholar
  11. Cohen IL. Criterion-related validity of the PDD behavior inventory. J Autism Dev Disord. 2003;33(1):47–53.PubMedCrossRefGoogle Scholar
  12. Cohen IL. PDD behavior inventory screening version professional manual. Lutz: Psychological Assessment Resources; 2011.Google Scholar
  13. Cohen IL, Sudhalter V. The PDD behavior inventory. Lutz: Psychological Assessment Resources; 2005a.Google Scholar
  14. Cohen IL, Sudhalter V. PDD behavior inventory professional manual. Lutz: Psychological Assessment Resources; 2005b.Google Scholar
  15. Cohen IL, Tsiouris J. Maternal recurrent mood disorders and high-functioning autism. J Autism Dev Disord. 2006;36:1077–8.PubMedCrossRefGoogle Scholar
  16. Cohen IL, Fisch GS, Sudhalter V, et al. Social gaze, social avoidance, and repetitive behavior in fragile X males: a controlled study. Am J Ment Retard. 1988;92(5):436–46.PubMedGoogle Scholar
  17. Cohen IL, Brown WT, Jenkins EC, et al. Fragile X syndrome in females with autism. Am J Med Genet. 1989a;34(2):302–3.PubMedCrossRefGoogle Scholar
  18. Cohen IL, Vietze PM, Sudhalter V, Jenkins EC, Brown WT. Parent-child dyadic gaze patterns in fragile X males and in non-fragile X males with autistic disorder. J Child Psychol Psychiatry. 1989b;30(6):845–56.PubMedCrossRefGoogle Scholar
  19. Cohen IL, Sudhalter V, Pfadt A, Jenkins EC, Brown WT, Vietze PM. Why are autism and the fragile-X syndrome associated? Conceptual and methodological issues. Am J Hum Genet. 1991a;48(2):195–202.PubMedGoogle Scholar
  20. Cohen IL, Vietze PM, Sudhalter V, Jenkins EC, Brown WT. Effects of age and communication level on eye contact in fragile X males and non-fragile X autistic males. Am J Med Genet. 1991b;38(2–3):498–502.PubMedCrossRefGoogle Scholar
  21. Cohen IL, Nolin SL, Sudhalter V, Ding XH, Dobkin CS, Brown WT. Mosaicism for the FMR1 gene influences adaptive skills development in fragile X-affected males. Am J Med Genet. 1996;64(2):365–9.PubMedCrossRefGoogle Scholar
  22. Cohen IL, Liu X, Schutz C, et al. Association of autism severity with a monoamine oxidase A functional polymorphism. Clin Genet. 2003a;64:190–7.PubMedCrossRefGoogle Scholar
  23. Cohen IL, Schmidt-Lackner S, Romanczyk R, Sudhalter V. The PDD behavior inventory: a rating scale for assessing response to intervention in children with PDD. J Autism Dev Disord. 2003b;33(1):31–45.PubMedCrossRefGoogle Scholar
  24. Cohen IL, Gomez TR, Gonzalez MG, Lennon EM, Karmel BZ, Gardner JM. Parent PDD behavior inventory profiles of young children classified according to autism diagnostic observation schedule-generic and autism diagnostic interview-revised criteria. J Autism Dev Disord. 2010a;40(2):246–54.PubMedCrossRefGoogle Scholar
  25. Cohen IL, Liu X, Lewis ME, et al. Autism severity is associated with child and maternal MAOA genotypes. Clin Genet. 2010b;79(4):355–62.CrossRefGoogle Scholar
  26. Coleman M, Gillberg C. The autisms. New York: Oxford University Press; 2012.Google Scholar
  27. Constantino JN, Davis SA, Todd RD, et al. Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised. J Autism Dev Disord. 2003;33(4):427–33.PubMedCrossRefGoogle Scholar
  28. Cote F, Fligny C, Bayard E, et al. Maternal serotonin is crucial for murine embryonic development. Proc Natl Acad Sci USA. 2007;104(1):329–34.PubMedCrossRefGoogle Scholar
  29. Croen LA, Najjar DV, Ray GT, Lotspeich L, Bernal P. A comparison of health care utilization and costs of children with and without autism spectrum disorders in a large group-model health plan. Pediatrics. 2006;118(4):e1203–11.PubMedCrossRefGoogle Scholar
  30. Davis LK, Hazlett HC, Librant AL, et al. Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A gene. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:1145–51. 5 Oct 2008.PubMedCrossRefGoogle Scholar
  31. Dawson G, Rogers S, Munson J, et al. Randomized, controlled trial of an intervention for toddlers with autism: the early start Denver model. Pediatrics. 2010;125(1):e17–23.PubMedCrossRefGoogle Scholar
  32. Deckert J, Catalano M, Syagailo YV, et al. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet. 1999;8(4):621–4.PubMedCrossRefGoogle Scholar
  33. Denney RM, Koch H, Craig IW. Association between monoamine oxidase A activity in human male skin fibroblasts and genotype of the MAOA promoter-associated variable number tandem repeat. Hum Genet. 1999;105:542–51.PubMedCrossRefGoogle Scholar
  34. Du L, Bakish D, Ravindran A, Hrdina PD. MAO-A gene polymorphisms are associated with major depression and sleep disturbance in males. Neuroreport. 2004;15(13):2097–101.PubMedCrossRefGoogle Scholar
  35. Filipek PA, Accardo PJ, Ashwal S, et al. Practice parameter: screening and diagnosis of autism: report of the quality standards subcommittee of the American academy of neurology and the child neurology society. Neurology. 2000;55(4):468–79.PubMedCrossRefGoogle Scholar
  36. Gotham K, Pickles A, Lord C. Standardizing ADOS scores for a measure of severity in autism spectrum disorders. J Autism Dev Disord. 2009;39(5):693–705.PubMedCrossRefGoogle Scholar
  37. Green DM, Swets JA. Signal detection theory and psychophysics. New York: Wiley; 1966.Google Scholar
  38. Happe F, Ronald A. The ‘fractionable autism triad’: a review of evidence from behavioural, genetic, cognitive and neural research. Neuropsychol Rev. 2008;18:287–304.PubMedCrossRefGoogle Scholar
  39. Herman AI, Kaiss KM, Ma R, et al. Serotonin transporter promoter polymorphism and monoamine oxidase type A VNTR allelic variants together influence alcohol binge drinking risk in young women. Am J Med Genet B Neuropsychiatr Genet. 2005;133B(1):74–8.PubMedCrossRefGoogle Scholar
  40. Johnson CP, Myers SM. Identification and evaluation of children with autism spectrum disorders. Pediatrics. 2007;120(5):1183–215.PubMedCrossRefGoogle Scholar
  41. Karmel BZ, Gardner JM, Meade LS, et al. Early medical and behavioral characteristics of NICU infants later classified with ASD. Pediatrics. 2010;126(3):457–67.PubMedCrossRefGoogle Scholar
  42. Kim J, Wigram T, Gold C. The effects of improvisational music therapy on joint attention behaviors in autistic children: a randomized controlled study. J Autism Dev Disord. 2008;38(9):1758–66.PubMedCrossRefGoogle Scholar
  43. Komoto J, Usui S, Otsuki S, Terao A. Infantile autism and Duchenne muscular dystrophy. J Autism Dev Disord. 1984;14(2):191–5.PubMedCrossRefGoogle Scholar
  44. Liu X, Malenfant P, Reesor C, et al. 2p15-p16.1 microdeletion syndrome: molecular characterization and association of the OTX1 and XPO1 genes with autism spectrum disorders. Eur J Hum Genet. 2011;19(12):1264–70.PubMedCrossRefGoogle Scholar
  45. Lord C, Rutter M, Le Couteur A. Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994;24:659–85.PubMedCrossRefGoogle Scholar
  46. Lord C, Rutter M, DiLavore PC, Risi S. Autism diagnostic observation schedule (ADOS). Los Angeles: Western Psychological Services; 1999. Manual ed.Google Scholar
  47. Malenfant P, Liu X, Hudson ML, et al. Association of GTF2i in the Williams-Beuren syndrome critical region with autism spectrum disorders. J Autism Dev Disord. 2012;42(7):1459–69.PubMedCrossRefGoogle Scholar
  48. Malmberg K, Wargelius HL, Lichtenstein P, Oreland L, Larsson JO. ADHD and disruptive behavior scores – associations with MAO-a and 5-HTT genes and with platelet MAO-B activity in adolescents. BMC Psychiatry. 2008;8:28. 23 Apr 2008.PubMedCrossRefGoogle Scholar
  49. Maron E, Lang A, Tasa G, et al. Associations between serotonin-related gene polymorphisms and panic disorder. Int J Neuropsychopharmacol. 2005;8(2):261–6.PubMedCrossRefGoogle Scholar
  50. May ME, Srour A, Hedges LK, et al. Monoamine oxidase a promoter gene associated with problem behavior in adults with intellectual/developmental disabilities. Am J Intellect Dev Disabil. 2009;114(4):269–73.PubMedCrossRefGoogle Scholar
  51. New York State Department of Health. Clinical practice guideline: report of the recommendations, autism/pervasive developmental disorders. In: Assessment and intervention for young children, (age 0–3 years). Albany: New York State Department of Health; 1999.Google Scholar
  52. Passamonti L, Fera F, Magariello A, et al. Monoamine oxidase-a genetic variations influence brain activity associated with inhibitory control: new insight into the neural correlates of impulsivity. Biol Psychiatry. 2006;59(4):334–40.PubMedCrossRefGoogle Scholar
  53. Robins DL, Fein D, Barton ML, Green JA. The modified checklist for autism in toddlers: an initial study investigating the early detection of autism and pervasive developmental disorders. J Autism Dev Disord. 2001;31(2):131–44.PubMedCrossRefGoogle Scholar
  54. Roohi J, DeVincent CJ, Hatchwell E, Gadow KD. Association of a monoamine oxidase-a gene promoter polymorphism with ADHD and anxiety in boys with autism spectrum disorder. J Autism Dev Disord. 2009;39(1):67–74.PubMedCrossRefGoogle Scholar
  55. Sabol SZ, Hu S, Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet. 1998;103(3):273–9.PubMedCrossRefGoogle Scholar
  56. Silva LM, Schalock M, Ayres R, Bunse C, Budden S. Qigong massage treatment for sensory and self-regulation problems in young children with autism: a randomized controlled trial. Am J Occup Ther. 2009;63(4):423–32.PubMedCrossRefGoogle Scholar
  57. Sjoberg RL, Ducci F, Barr CS, et al. A non-additive interaction of a functional MAO-A VNTR and testosterone predicts antisocial behavior. Neuropsychopharmacology. 2008;33(2):425–30.PubMedCrossRefGoogle Scholar
  58. Sparrow SS, Cicchetti DV, Balla DA. Vineland-II survey forms manual. Minneapolis: Pearson; 2005.Google Scholar
  59. Stone WL, McMahon CR, Henderson LM. Use of the screening tool for autism in two-year-olds (STAT) for children under 24 months: an exploratory study. Autism. 2008;12(5):557–73.PubMedCrossRefGoogle Scholar
  60. Warren Z, McPheeters ML, Sathe N, Foss-Feig JH, Glasser A, Veenstra-VanderWeele J. A systematic review of early intensive intervention for autism spectrum disorders. Pediatrics. 2011;127(5):e1303–11.PubMedCrossRefGoogle Scholar
  61. Wu JY, Kuban KC, Allred E, Shapiro F, Darras BT. Association of Duchenne muscular dystrophy with autism spectrum disorder. J Child Neurol. 2005;20(10):790–5.PubMedCrossRefGoogle Scholar
  62. Zwaigenbaum L, Tarnopolsky M. Two children with muscular dystrophies ascertained due to referral for diagnosis of autism. J Autism Dev Disord. 2003;33(2):193–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of PsychologyNYS Institute for Basic Research in Developmental DisabilitiesStaten IslandUSA

Personalised recommendations